Clinical and Pharmacological, Organizational and Legal, Forensic and Pharmaceutical Research of Drugs of ATC-Group N01AX03 for Anesthesia

Authors

DOI:

https://doi.org/10.53933/sspmpm.v3i2.90

Keywords:

pharmacy organization and management, clinical pharmacy, forensic pharmacy, control regime, anesthetics, ketamine

Abstract

Clinical and pharmacological, organizational and legal, forensic and pharmaceutical study of drugs of the N01AX03 group for anesthesia was conducted. A clinical and pharmacological research based on the results of a documentary analysis in a retrospective measurement of indicators of clinical-pharmaceutical safety of ketamine showed that ketamine became the first non-inhalation anesthetic. It causes dissociative anesthesia with an analgesic effect. It is used in emergency surgery, during evacuation in combat conditions, in cardiac surgery, dentistry, ophthalmology, otorhinolaryngology, gynecology. It is prescribed for patients with traumatic shock and blood loss. The organizational and legal research based on the results of the study of the marketing, classification, legal, nomenclature and legal indicators of drugs with ATC code N01AX03 showed the circulation on the pharmaceutical market of Ukraine of 4fourpsychotropic, prescription drugs of ketamine in the form of ampoules and vials for intramuscular and intravenous administration. Forensic and pharmaceutical research based on the results of the study of the control regime, availability, cases from forensic pharmaceutical practice, legal responsibility for the illegal circulation of drugs with ATS code N01AX03 made it possible to establish a direct relationship between the indicated indicators.

Author Biography

Alina Osyntseva, Lugansk State Medical University

PhD in Pharmaceutical Sciences, Luhansk State Medical University

Public Organization “Association of medical and pharmaceutical law”

References

Shapovalov V. Multidisciplinary study of the level of availability of medicines for cancer patients based on the principles of pharmaceutical law, evidence-based pharmacy, clinical pharmacy, forensic pharmacy, and the organization of a pharmaceutical case. Actual Problems of Medicine and Pharmacy. 2023. Vol.4. No.1. P.1–20. URL: https://doi.org/10.52914/apmp.v4i1.52. DOI: https://doi.org/10.52914/apmp.v4i1.52

Osyntseva A. Cannabinoid addiction: pharmacotherapy, forensic and pharmaceutical practice, availability of drugs. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.1. P.1-11. URL: https://doi.org/10.53933/sspmpm.v3i1.83. DOI: https://doi.org/10.53933/sspmpm.v3i1.83

Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P.1–24. URL: https://doi.org/10.53933/sspmpm.v2i4.69. DOI: https://doi.org/10.53933/sspmpm.v2i4.69

Shapovalova V.A., Zbrozhek S.I., Shapоvalov V.V. et al. Coronavirus disease pandemia 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences. 2020. Vol. 4. Iss. 7. P. 61–68. URL: https://www.actascientific.com/ASPS/ASPS-04-0559.php. DOI: https://doi.org/10.31080/ASPS.2020.04.0559

Shapovalov (Jr.) V., Shapovalova V., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. N.1. July-August 2018. Article N. 18, P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.

Shapovalova V. An Innovative multidisciplinary study of the availability of coronavirus vaccines in the world. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.2. P.1-17 URL: https://doi.org/10.53933/sspmpm.v2i2.45. DOI: https://doi.org/10.53933/sspmpm.v2i2.45

Shapovalova V. Monkeypox virus – new challenges of modernity: experimental organizational and legal, clinical and pharmacological studies. SSP Modern Pharmacy and Medicine. 2022. Vol.2. N.3. P.1-15. URL: https://doi.org/10.53933/sspmpm.v2i3.54. DOI: https://doi.org/10.53933/sspmpm.v2i3.54

Smith J. Enhancing affected person care and the scope of apply for pharmacists, scholar pharmacists by immunizations throughout the monkeypox outbreak. Monkeypox Breaking news. 21.12.2022. URL: https://monkeypox-treatment.com/enhancing-affected-person-care-and-the-scope-of-apply-for-pharmacists-scholar-pharmacists-by-immunizations-throughout-the-monkeypox-outbreak/.

Nikholas. Patient care. Enhancing patient care and the scope of practice for pharmacists, student pharmacists through immunizations during the monkeypox outbreak. Hide my health. Trending Now. HUR Siege. 2022. URL: https://hidemyhealth.com/enhancing-patient-care-and-the-scope-of-practice-for-pharmacists-student-pharmacists-through-immunizations-during-the-monkeypox-outbreak.html.

Shapovalov V.V. (Jr.), Shapovalova V.A., Shapovalov V.V. Forensic and pharmaceutical research on the impact of drugs on the safety, life and health of road users within the organization of pharmaceutical business, drug technology, pharmaceutical and medical law in Ukraine. Health of Society. 2021. Vol.10. Nо.4. P.127-132. URL: https://doi.org/10.22141/2306-2436.10.4.2021.246355. DOI: https://doi.org/10.22141/2306-2436.10.4.2021.246355

Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. N.1. P.1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37. DOI: https://doi.org/10.53933/sspmpm.v2i1.37

Shapovalova V. Alcoholic Hepatitis: An Experimental Meta-Analysis. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.1. P.1-11. DOI: https://doi.org/10.53933/sspmpm.v3i1.77. DOI: https://doi.org/10.53933/sspmpm.v3i1.77

Shapovalova V. Interdisciplinary pharmacoeconomic research concerning the pharmacotherapy of Аlcoholic Hepatitis in conditions of COVID-19 pandemic. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.2. P.1-10. URL: https://doi.org/10.53933/sspmpm.v3i2.87. DOI: https://doi.org/10.53933/sspmpm.v3i2.87

Sosin I.K., Chuev Yu.F., ArtemchukA.P., Shapovalova V.O. Shapovalov Valentyn. V et al. Narcology: national textbook. Kharkiv, Ukraine: Kolegium.2014. 948 p.

Shapovalova V.A., Voloshyn P.V., Stefanov A.V. et al. Medicines for neurologists, psychiatrists and narcologists. Kh.: «Fakt». 2003. 784 p.

Shapovalova V.A., Sosyn I.K., Butenko G.M. et al. Pharmaceutical law in narcology. Kharkiv: "Fact". 2004. 800 p.

Gubskyi Y.I., Shapovalova V.O., Kutko I.I. et al. Medicines in psychopharmacology. K.: "Health", Kharkiv: "Torsing".1997. 288 p.

Shapovalov V. (Jr.), Gudzenko A., Shapovalova V. at. el. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017. Vol.66. Nо.3. Р. 31-39. URL: http://bsphs.org/wp-content/uploads/2017/11/Shapovalov.pdf.

Shapovalova V. A., Shapovalov V. V. Handbook of legal and forensic pharmacy. Kharkiv.: Torsing.1997. 656 p.

Shapovalova V., Zakharchenko I. Organizational and legal approaches to reforming of the law enforcement system of Ukraine: illegal circulation of psychoactive substances and addictive dependence. SSP Modern Law and Practice. 2021. Vol. 1. Nо.1. P.1–22. URL: https://doi.org/10.53933/sspmlp.v1i1.20. DOI: https://doi.org/10.53933/sspmlp.v1i1.20

Tukhar I., Shapovalova V., Shapovalov V. et al. Pharmacological view on the problem of comorbidity in the pharmacotherapy of chronic pancreatitis. Science Review. Vol.3. No.38. P.1-5. URL: https://doi:10.31435/rsglobal_sr/30072021/7591. DOI: https://doi.org/10.31435/rsglobal_sr/30072021/7591

Shapovalov V. (Jr.), Gudzenko А., Shapovalova V. et al. Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines. Pharmacia. 2017. Vol.65. Nо.2. P.23–29. URL: http://bsphs.org/wp-content/uploads/2017/07/Shapovalov.pdf.

UNODC World Drug Report 2022 highlights trends on cannabis post-legalization, environmental impacts of illicit drugs, and drug use among women and youth. Press release. UN. Vienna. 27.06.2022. URL: https://www.unodc.org/unodc/en/press/releases/2022/June/unodc-world-drug-report-2022-highlights-trends-on-cannabis-post-legalization--environmental-impacts-of-illicit-drugs--and-drug-use-among-women-and-youth.html.

Chuiev Yu., Shapovalova V. Interdisciplinary pharmacoeconomic study of pharmacotherapy of cupping of drunk forms of alcohol dependence: clinical and pharmacological, organizational, legal and marketing experiment. SSP Modern Pharmacy and Medicine. 2021. Vol.1. Nо.2. P.1-12. URL: https://doi.org/10.53933/sspmpm.v1i2.24. DOI: https://doi.org/10.53933/sspmpm.v1i2.24

Shapovalov V.V., Gudzenko A.A., Shapovalova V., Zbrozhek S.I. et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of psychotropic psychoactive substances in Ukraine (retrospective aspect). Annals of Mechnikov Institute. 2018. N. 3. Р. 41–44. DOI: 10.5281/zenodo.1456544. URL: http://www.imiamn.org.ua/journal/3_2018/PDF/9.pdf.

Shapovalova V.A., Zbrozhek S.I., Shapovalov V.V. et al. Forensic pharmacy: some risk factors in the formation of addictive health disorders. Acta Scientific Pharmaceutical Science. 2021. Vol.5. Iss.1. P.54-59. DOI: 10.31080/ASPS.2020.05.0651. URL: https://actascientific.com/ASPS/ASPS-05-0651.php. DOI: https://doi.org/10.31080/ASPS.2020.05.0651

Nehretskii S. Forensic and pharmaceutical, organizational and legal studies of illegal circulation, danger and drug addiction from cannabinoids. SSP Modern Pharmacy and Medicine. 2022. Vol.2. No.4. P.1-15. URL: https://doi.org/10.53933/sspmpm.v2i4.71. DOI: https://doi.org/10.53933/sspmpm.v2i4.71

Hayduchok I., Tukhar I., Shapovalov V. Chronic Pancreatitis, comorbid with alcohol addiction: epidemiology, causes, developmental features, symptoms and supportive pharmaceutical therapy. SSP Modern Pharmacy and Medicine. 2022. Vol.2. No.2. P.1-13. URL: https://doi.org/10.53933/sspmpm.v2i2.46. DOI: https://doi.org/10.53933/sspmpm.v2i2.46

Gelen S., Sarper N., Demirsoy U. et al. The Efficacy and Safety of procedural sedoanalgesia with Midazolam and Ketamine in pediatric hematology. Turk. J. Hematology. 2015. No.32. P.351-354. URL: https://pubmed.ncbi.nlm.nih.gov/25913821/. DOI: https://doi.org/10.4274/tjh.2014.0149

Shapovalov V., Veits O. Forensic and pharmaceutical, criminal and legal, social and economic study of the conditions, that cause bribery corruption in the system of legal relations "doctor-patient-investigator-lawyer". SSP Modern Law and Practice. 2022. Vol.2. No.3. P.1-16. URL: https://doi.org/10.53933/sspmlp.v2i3.57. DOI: https://doi.org/10.53933/sspmlp.v2i3.57

Jansen K. Ketamine: Dreams and Realities. Multidisciplinary Association for Psychedelic Studies. 2001. P.23 URL: https://maps.org/images/pdf/books/K-DreamsKJansenMAPS.pdf.

Bonanno F.G. Ketamine in war/tropical surgery (a final tribute to the racemic mixture). Injury J. 2002. Vol.33. No.4. P.323-327. URL: Injury 2002-05: Vol 33 Iss 4: Free Download, Borrow, and Streaming : Internet Archive. DOI: https://doi.org/10.1016/S0020-1383(01)00209-1

White P.F., Way W.L., Trevor A.J. Ketamine--its pharmacology and therapeutic uses. 1982. URL: https://pubmed.ncbi.nlm.nih.gov/6892475/. DOI: https://doi.org/10.1097/00000542-198202000-00007

Calvey N., Williams N. Principles and Practice of Pharmacology for Anaesthetists. Wiley-Blackwell. 2001. 357p. URL: https://archive.org/details/principlespracti0000calv.

Bergman S.A. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesthesia Progress Journal. 1999. Vol. 46. No.1. P.10—20. URL: https://pubmed.ncbi.nlm.nih.gov/10551055/.

Olney W., Labruyere J., Price M. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 1989. Vol.244. No.4910. P.1360-1362. URL: https://pubmed.ncbi.nlm.nih.gov/2660263/. DOI: https://doi.org/10.1126/science.2660263

White P., Ham J., Way W. et al. Pharmacology of ketamine isomers in surgical patients. Anesthesiology Journal. 1980. Vol. 52. No.3. P. 231-239. URL: https://pubmed.ncbi.nlm.nih.gov/10551055/. DOI: https://doi.org/10.1097/00000542-198003000-00008

Grant I.S., Nimmo W.S., McNicol L.R. et al. Ketamine disposition in children and adults. British Journal Anaesth. 1983. Vol.55. No.11. P.1107-1111. URL: https://pubmed.ncbi.nlm.nih.gov/6639827/. DOI: https://doi.org/10.1093/bja/55.11.1107

Elia N., Tramèr M. Ketamine and postoperative pain--a quantitative systematic review of randomised trials. Painl. 2005. Vol.113. No.1-2. P.61-70. URL: https://pubmed.ncbi.nlm.nih.gov/15621365/. DOI: https://doi.org/10.1016/j.pain.2004.09.036

Shaprio H., Wyte S., Harris A. Ketamine anaesthesia in patients with intracranial pathology. British Journal Anaesth. 1972. Vol. 44. No.11. P.1200-1204. URL: https://pubmed.ncbi.nlm.nih.gov/4647115/. DOI: https://doi.org/10.1093/bja/44.11.1200

Dawson B., Michenfelder J., Theye R. Effects of ketamine on canine cerebral blood flow and metabolism: modification by prior administration of thiopental. Anesth Analg. 1971. Vol. 50. No. 3. P. 443-447. URL: https://pubmed.ncbi.nlm.nih.gov/5103782/. DOI: https://doi.org/10.1213/00000539-197105000-00035

Thorsen T., Gran L. Ketamine/diazepam infusion anaesthesia with special attention to the effect on cerebrospinal fluid pressure and arterial blood pressure. Acta Anaesthesiol Scand. 1980.Vol. 24. No. 1. P. 1-4. URL: https://pubmed.ncbi.nlm.nih.gov/7376798/. DOI: https://doi.org/10.1111/j.1399-6576.1980.tb01494.x

Han Y., Chen J., Zou D. et al. Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies. Neuropsychiatric Disease and Treatment. 2016. No. 12. P. 2859-2867. URL: https://pubmed.ncbi.nlm.nih.gov/27843321/. DOI: https://doi.org/10.2147/NDT.S117146

Rakesh G., Pae C., Masand P. Beyond serotonin: newer antidepressants in the future. Expert Review of Neurotherapeutics. 2017. No. 17. P. 777—790. URL: https://pubmed.ncbi.nlm.nih.gov/28598698/. DOI: https://doi.org/10.1080/14737175.2017.1341310

Esketamine-Johnson&Johnson. 23.03.2023. URL: https://adisinsight.springer.com/drugs/800037644.

FDA Advisory Committee Recommends Approval of SPRAVATO™ (esketamine) Nasal Spray CIII for Adults with Treatment-Resistant Depression. Janssen. Johnson&Johnson. 12.02.2019. URL: https://www.janssen.com/fda-advisory-committee-recommends-approval-spravato-esketamine-nasal-spray-ciii-adults-treatment.

Ng J. et al. Efficacy of Ketamine and Esketamine on Functional Outcomes in Treatment-Resistant Depression: A Systematic Review. Journal of Affective Disorders. 2021. URL: https://www.sciencedirect.com/science/article/abs/pii/S0165032721006182. DOI: https://doi.org/10.1016/j.jad.2021.06.032

Williams N., Heifets B., Blasey C. et al. Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. The American Journal of Psychiatry. 2018. Vol.175. No.12. P.1205-1215. URL: https://pubmed.ncbi.nlm.nih.gov/30153752/. DOI: https://doi.org/10.1176/appi.ajp.2018.18020138

Cohut M. Testing whether ketamine acts like an opioid. Medical News Today. 29.08.2018. URL: https://www.medicalnewstoday.com/articles/322909

ATC-classification. Compendium on-line. URL: http://compendium.com.ua/atc.

Hayduchok I., Shapovalova V., Ishcheikin K. et al. Pharmaeconomic approaches for pharmacotherapy of Rheumatoid arthritis. Likars’ka Sprava. 2021. No. 1–2. P.70-79. https://doi.org/10.31640/JVD.1-2.2021(11). URL: https://liksprava.com/index.php/journal/article/view/463. DOI: https://doi.org/10.31640/JVD.1-2.2021(11)

Shapovalov (Jr.) V., Gudzenko A., Shapovalova V., Shapovalov V. Forensic and pharmaceutical analysis of addictive morbidity because of the use of narcotic psychoactive substances in Ukraine (retrospective aspect). International Journal of Pharmaceutical Sciences and Research. 2018. Vol. 3. Is.3. P.22-25. URL: http://www.pharmacyjournal.net/archives/2018/vol3/issue3.

Criminal Code of Ukraine. Verkovna Rada of Ukraine. URL: https://zakon.rada.gov.ua/laws/show/2341-14/page15#Text.

Downloads

Published

2023-05-01

How to Cite

Osyntseva, A. (2023). Clinical and Pharmacological, Organizational and Legal, Forensic and Pharmaceutical Research of Drugs of ATC-Group N01AX03 for Anesthesia. SSP Modern Pharmacy and Medicine, 3(2), 1–10. https://doi.org/10.53933/sspmpm.v3i2.90

Issue

Section

Health Sciences. Pharmacy